B-cell lymphoma in the 3L+ setting 83% overall response and 61% complete response rates in cohort comprised predominantly of patients with primary refractory large B-cell lymphoma in the 2L setting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback